✦ LIBER ✦

IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation

✍ Scribed by Lawrence, Toby; Bebien, Magali; Liu, George Y.; Nizet, Victor; Karin, Michael

Book ID: 109894094
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 544 KB
Volume: 434
Category: Article
ISSN: 0028-0836
DOI: 10.1038/nature03491

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Limited availability ofl-arginine increa

Limited availability ofl-arginine increases DNA-binding activity of NF-κB and contributes to regulation of iNOS expression

✍ Guido Kagemann; Helmut Sies; Oliver Schnorr 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 493 KB

Intracellular LPS inhibits the activity

Intracellular LPS inhibits the activity of potassium channels and fails to activate NFκB in human macrophages

✍ Anja Gerth; Jens Grosche; Karen Nieber; Sunna Hauschildt 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

## Abstract Although much has been learned about signal transduction mechanisms and binding proteins involved in lipopolysaccharides (LPS)‐induced activation of monocytes/macrophages, little is known about the ability of internalized LPS to activate cells. To approach this question we either expose

Suppression of TNFα-mediated NFκb activi

Suppression of TNFα-mediated NFκb activity by myricetin and other flavonoids through downregulating the activity of IKK in ECV304 cells

✍ Shu-Huei Tsai; Yu-Chih Liang; Shoei-Yn Lin-Shiau; Jen-Kun Lin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

Flavonoids are a group of naturally-occurring phenolic compounds in the plant kingdom, and many flavonoids are found with vascular protective properties. Nevertheless how the protective response is exerted by flavonoids is not well characterized. In view of the nuclear factor-B (NFB) may play a cent

Receptor activator of NF-κB ligand, macr

Receptor activator of NF-κB ligand, macrophage inflammatory protein-1α, and the proteasome : Novel therapeutic targets in myeloma

✍ Babatunde O. Oyajobi; Gregory R. Mundy 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Background: The bone destruction in myeloma patients is largely responsible for the clinical features of the disease. however, only recently has attention focused on identifying and developing drugs targeted specifically at the osteolysis. receptor activator of nf-kappab ligand (rankl), macropha

Activation of the NF-κB pathway by the l

Activation of the NF-κB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKα

✍ Malinge, S; Monni, R; Bernard, O; Penard-Lacronique, V 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB

Activation of the nuclear factor kappa B

Activation of the nuclear factor kappa B (NF-κB) and cyclooxygenase-2 (COX-2) genes in cerebral blood vessels in response to systemic inflammation

✍ Rivest, S 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 51 KB